Long-Term Effects of Olmesartan, an Ang II Receptor Antagonist, on Blood Pressure and the Renin-Angiotensin-Aldosterone System in Hypertensive Patients.
Author:
Publisher
Japanese Society of Hypertension
Subject
Cardiology and Cardiovascular Medicine,Physiology,Internal Medicine
Reference20 articles.
1. Angiotensin II Receptor Antagonists: An Emerging New Class of Cardiovascular Therapeutics.
2. Pharmacology of CS-866, a novel nonpeptide angiotensin II receptor antagonist
3. Nonpeptide Angiotensin II Receptor Antagonists: Synthesis, Biological Activities, and Structure−Activity Relationships of Imidazole-5-carboxylic Acids Bearing Alkyl, Alkenyl, and Hydroxyalkyl Substituents at the 4-Position and Their Related Compounds
4. Clinical studies of CS-866, the newest angiotensin II receptor antagonist
5. Blood pressure and endocrine effects of single doses of CS-866, a novel angiotensin II antagonist, in salt-restricted hypertensive patients
Cited by 42 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Are the Newest Angiotensin Receptor Blockers Preferred than the Old Members in COVID-19 Patients with Cardiovascular Comorbidity?;International Journal of Pharmacology;2021-07-15
2. Role of the renin–angiotensin system in the development of cataract formation in angiotensin‐II‐induced experimental rats;Journal of Biochemical and Molecular Toxicology;2021-04-13
3. Losartan protects against intermittent hypoxia-induced peritubular capillary loss by modulating the renal renin–angiotensin system and angiogenesis factors;Acta Biochimica et Biophysica Sinica;2019-12-14
4. Practical efficacy of olmesartan versus azilsartan in patients with hypertension;Blood Pressure Monitoring;2017-04
5. The effects of different angiotensin II type 1 receptor blockers on the regulation of the ACE-AngII-AT1 and ACE2-Ang(1–7)-Mas axes in pressure overload-induced cardiac remodeling in male mice;Journal of Molecular and Cellular Cardiology;2016-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3